From cost–effectiveness ratios to resource allocation: where to draw the line?
The DOI matches its Crossref record.
Abstract
In recent years, cost–effectiveness analysis has been the most prevalent type of economic evaluation of health care interventions, including pharmaceuticals (Torrance 1986; Eisenberg 1989; Detsky and Naglie 1990; Freund and Dittus 1992). Unlike cost–benefit analysis, which requires that health outcomes be valued in monetary units in order to calculate the net economic benefit of a program, cost–effectiveness analysis requires only that a quantitative measure of health effectiveness, or utility, be defined. Typically, effectiveness is measured by life years (LYs) or quality-adjusted life years (QALYs). The cost–effectiveness ratio (dollars per LY or dollars per QALY) serves as a yardstick for measuring the relative priority of health interventions that compete for limited resources. Perhaps because it avoids translating health consequences into dollars, cost–effectiveness analysis has been more favorably received by the medical community than cost–benefit analysis and has been favored by government agencies that have proposed or adopted economic criteria for funding of health programs or paying for new drugs (Klevit et al. 1991; Henry 1992). Although economic valuation of health consequences is avoided in the analysis per se, the problem of deciding in absolute terms whether a program is worth funding or not rests on whether a particular value of the cost–effectiveness ratio (e.g., $100,000 per QALY) is acceptable. Following a review of the theoretical framework that leads to the use of the cost–effectiveness ratio as a decision criterion, this chapter addresses three issues in interpreting cost–effectiveness ratios and in translating them into criteria for resource allocation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,102
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850
Eichler, H.-G., Kong, S. X., Gerth, W. C., Mavros, P., & Jönsson, B. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.75003.x · Cited by 788
National Institute for Clinical Excellence and its value judgments
Rawlins, M. D., & Culyer, A. J. (2004) · BMJ · doi:10.1136/bmj.329.7459.224 · Cited by 765
Metadata
- Authors
- Weinstein, M. C.
- Venue
- Valuing Health Care
- Publisher
- Cambridge University Press
- Published
- 1995-01-27
- Pages
- 77-98
- OpenAlex
- W1832993665
- Cited by
- 132
- References
- 0
- FWCI
- 20.07
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From cost–effectiveness ratios to resource allocation: where to draw the line? https://app.cochat.ai/papers/10.1017/cbo9780511625817.005
- The paper
- Weinstein, M. C. (1995). From cost–effectiveness ratios to resource allocation: where to draw the line? Valuing Health Care. https://doi.org/10.1017/cbo9780511625817.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.